SEC Filing Details

Document Details

Form
3
Filing Date
Jun 11, 2024
Document Date
Jun 5, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
YOSHIYAMA ANNIE